Back to search

Article

Detecting tumor-associated peptides from the plasma-derived soluble immunopeptidome in human hepatocellular carcinoma patients: a pilot study

2026-07-07

Abstract excerpt

<title>Abstract</title> <p>Background and aims. Hepatocellular carcinoma (HCC) shows limited response to checkpoint inhibitor therapy, leaving opportunities for antigen-based immunotherapy and improved disease monitoring. This study evaluates the plasma-derived soluble HLA-I (sHLA-I) peptidome as a minimally invasive source of tumor-associated antigens (TAAs) for personalized treatment and diagnostics in HCC. Met...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6534c43f-0e44-5058-81b9-0aea45283f7e
DOI
10.21203/rs.3.rs-9929854/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Detecting tumor-associated peptides from the plasma-derived soluble immunopeptidome in human hepatocellular carcinoma patients: a pilot studyDOI 10.21203/rs.3.rs-9929854/v1
Select a neighboring publication to make it the new centre.